Today's Stock News: Latest Updates on Public Companies

At a glance

On October 2, 2026, Freeport-McMoRan reported Q3 copper production of approximately 830 million pounds; Rivian produced 19,751 and delivered 19,248 vehicles and reaffirmed 2026 delivery guidance of 65,000–70,000; Surrozen won FDA IND clearance for SZN-8141 and expects ~$95.1 million in gross proceeds from a financing closing around October 20, 2026.

Earnings and operational updates

Freeport-McMoRan (FCX) provided third-quarter 2026 operational update reporting copper production of approximately 830 million pounds and gold production of approximately 230 thousand ounces; it expects copper sales to approximate its July estimate of 750 million pounds and unit net cash costs about 5% above July’s $2.00-per-pound estimate.

Rivian Automotive (RIVN) released Q3 2026 production and delivery figures saying it produced 19,751 vehicles and delivered 19,248 in Q3 and reaffirmed 2026 delivery guidance of 65,000–70,000 vehicles; third-quarter financial results will be released October 29, 2026.

Integra LifeSciences Holdings (IART) announced preliminary third-quarter results and updated full-year 2026 guidance estimating Q3 revenue of approximately $410 million to $412 million and adjusted EPS of $0.55–$0.59 while lowering full-year revenue guidance to $1.634 billion–$1.654 billion due to flooding impacts.

Deals and acquisitions

Aura Minerals (AUGO) signed definitive agreement to acquire Newco and insource mining fleet for Apoena, Almas and Borborema with an enterprise value of R$612 million (approximately $118 million), including up to R$250 million cash and assumed equipment lease financing.

TNL Mediagene (TNMG) entered definitive agreement to sell its Japanese business in a management buyout for $5.5 million, with adjustments capped at $500,000 and at least $4.5 million due or satisfied at closing and the unpaid balance as a secured note maturing December 31, 2026.

Cuprina Holdings (Cayman) (CUPR) to acquire East Coast Podiatry and Orchard Clinic via its subsidiary for approximately S$4.0 million consideration split into S$3.0 million cash (with S$0.5M at signing, S$1.35M at closing, S$1.15M deferred) and S$1.0 million in Class A shares, expected to complete on or before November 1, 2026.

5E Advanced Materials (FEAM) completed acquisition of Searles Valley Minerals' assets through a court-supervised bankruptcy sale, adding U.S. boron and critical minerals production assets and operations at Trona, California.

Financings and offerings

NN (NNBR) announced a $50 million net private placement expected to generate approximately $50 million in net proceeds from 10 investors by issuing common shares or pre-funded warrants at $3.30 per share (or $3.29 per warrant), closing on or about October 5, 2026.

Pyxis Oncology (PYXS) closed up to $282.6 million public offering raising approximately $110.0 million in upfront gross proceeds from issuance of 36,047,919 common shares at $2.90 and pre-funded warrants, with common warrants convertible to additional proceeds up to ~$282.6 million on full exercise.

Bally's (BALY) closed financing to support Bally’s Bronx project receiving initial term loan funding of $400 million led by WhiteHawk Capital Partners, with an additional $160 million in delayed draw commitments available.

Regulatory and clinical milestones

Surrozen (SRZN) announced FDA clearance of its IND for SZN-8141 enabling clinical development in diabetic macular edema and said it expects to dose the first DUET Phase 1b/2a patient in Q4 2026 and to satisfy a financing milestone that would allow a closing on or about October 20, 2026 to provide approximately $95.1 million in gross proceeds.

Ultragenyx Pharmaceutical (RARE) announced EMA validation of its MAA for rebisufligene etisparvovec for Sanfilippo syndrome Type A, confirming the application is complete enough to enter formal scientific review under the EU Joint Clinical Assessment framework.

Listings, corporate actions and compliance

iTonic Holdings (ITOC) announced a 16-for-1 share consolidation effective October 6, 2026 at 12:01 a.m. ET, reducing outstanding Class A shares from 109,382,000 to about 6,836,375 and Class B from 7,668,000 to about 479,250, subject to Nasdaq not objecting.

Phaos Technology Holdings (Cayman) (POAS) announced a one-for-fifteen reverse stock split expected to take effect October 12, 2026, consolidating every fifteen Class A or Class B ordinary shares into one.

Liberty Defense Holdings (DETX) announced sale of two HEXWAVE systems with Wadsworth Solutions to Cleveland Hopkins International Airport for deployment in the airport’s Aviation Worker Screening program.

Other notable news

Aureus Greenway Holdings (PUSA) completed its merger with Powerus and renamed Powerus Corporation effective October 1, 2026, with the combined company trading on Nasdaq under the symbol PUSA.

Satellogic (SATL) announced successful launch of its first Merlin satellite sending Merlin.01 and three NewSat satellites to LEO on October 1, 2026 aboard a SpaceX Falcon 9, with all satellites contacting the company’s ground station network and Merlin entering Launch and Early Orbit Phase.

Verra Mobility (VRRM) appointed Jon Newhard as President and Chief Executive Officer effective November 1, 2026, succeeding Interim CEO Jon Keyser who will remain as an advisor to support the transition.